Evaluation of the GORE® C3 Delivery System Module

W.L.Gore & Associates399 enrolled

Overview

This is an observational Registry designed to obtain early data on the use of the GORE® EXCLUDER® AAA Endoprosthesis with C3 Delivery System.

This is a retrospective and prospective observational cohort Registry designed to obtain data on the use of the GORE® EXCLUDER® AAA Endoprosthesis with C3 Delivery System. Patient and device performance outcomes will be collected during treatment and throughout all post-treatment visits, including follow-up extending up to 10 years.

Study Type

OBSERVATIONAL

Enrollment

399

Conditions

Aortic Aneurysm, Abdominal

Interventions

Stent graft (EXCLUDER)DEVICE

Endovascular repair

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: 1. Minimum age required by local regulations (as applicable) 2. Indication for aortic endovascular stent graft repair as determined by the treating physician (refer to current Instructions for Use of the GORE® EXCLUDER® AAA Endoprosthesis with C3 Delivery System)

Locations (1)

Klinikum Nürnberg-Süd

Nuremberg, Germany

Outcomes

Primary Outcomes

Evaluate procedural outcomes for the GORE® EXCLUDER® AAA Endoprosthesis with C3 Delivery System when used in accordance with the standard medical practice at each participating hospital.

Time frame: Up to 10 Years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.